Health ❯ Healthcare

Precision Medicine

Personalized Treatment Targeted Therapy Personalized Therapy Personalized Medicine Genomic Medicine Genetic Testing Personalized Care Treatment Strategies Targeted Therapies Therapeutic Targets Advanced Diagnostic Tests Microbiome Genomic Integrity Genetic Research Early Detection Treatment Response Microbiome Research Theranostics Government Initiatives Treatment Selection Targeted Treatments Patient Selection Genomic Research Factors Influencing Treatment Genomic Analysis Risk Assessment Risk Factors ctDNA Testing Genetic Variation Genetic Variants Genetic Mutations Combination Therapy Translational Research Genomic Testing Drug Development Therapeutic Interventions Biomarkers Research and Development Genetic Profiling Predictive Modeling Treatment Decision-Making Diagnostic Tests Cancer Avatar Program Therapeutic Applications Treatment Outcomes Molecular Profiling Functional Precision Medicine Patient Outcomes Treatment Personalization Genetics Therapeutic Development Oncology

BIOPREVENT, a Biomarker‑AI Tool, Predicts Post‑Transplant cGVHD and Mortality Months Early

Validated in an independent cohort, the tool is now available as a free research web app pending clinical trials.

CU Anschutz Study Uses Blood ‘Omics’ to Predict Trauma Recovery Days Ahead

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

Intellicule Wins $217,941 NIH SBIR Phase I Grant for AI Cryo-EM Modeling Tools

Hi-C–Based 3D Genome Mapping Tool Exposes Hidden Structural Variants in Clinical Study

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial

Long-Term ASAP Trial Finds Disease Risk, Not Remission, Drives AML Transplant Survival

European Commission Approves Voranigo for IDH-Mutant Grade 2 Glioma

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Mount Sinai Team Publishes AI ‘Penetrance’ Scores to Gauge Disease Risk From Rare Variants

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

AI-Guided Pythia Steers CRISPR Edits Toward Precise DNA Integration

Pharmacogenetic Screening Halves Severe Chemotherapy Reactions in Gastrointestinal Cancer Patients

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

UCSD Validates STRESS Signature, Pursues Inhibitors to Block Pancreatic Cancer Progression

moPepGen Graph Algorithm Quadruples Protein Variant Detection in Tumor Samples

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial